Zhu Hui, Hou Yan-Bo, Gao Ji-Guo, Zhao Teng, Zhou Chun-Kui, Liu Jing-Yao
Department of Neurology, The First Hospital, Jilin University, Changchun, China.
Neuro Endocrinol Lett. 2018 May;39(2):85-87.
We report a case of a 51-year-old man with limbic encephalitis (LE) associated with antibodies against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor (AMPAR). The patient presented with anterograde memory loss for 2 months. Cranial magnetic resonance and electroencephalogram were normal. AMPAR antibodies were found in blood serum and cerebrospinal fluid. All other test results were unremarkable. CT scans found a tumor in the right lobus superior pulmonis. A CT-guided needle biopsy was performed and pathological results showed small cell lung cancer (SCLC). The patient was diagnosed with LE associated with AMPAR antibodies and SCLC. Three months after immunotherapy and tumor removal, patient's memory was partially restored. We recommend that AMPAR antibodies should be detected in patients with classic LE with or without tumor. Prompt treatment of the tumor and immunotherapy are important.
我们报告一例51岁男性患边缘性脑炎(LE),伴有抗α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体(AMPAR)抗体。患者出现顺行性记忆丧失2个月。头颅磁共振成像和脑电图正常。血清和脑脊液中发现了AMPAR抗体。所有其他检查结果均无异常。CT扫描发现右肺上叶有一个肿瘤。进行了CT引导下针吸活检,病理结果显示为小细胞肺癌(SCLC)。该患者被诊断为与AMPAR抗体和SCLC相关的LE。免疫治疗和肿瘤切除3个月后,患者的记忆部分恢复。我们建议,对于有或无肿瘤的典型LE患者,均应检测AMPAR抗体。及时治疗肿瘤和免疫治疗很重要。